je.st
news
GlaxoSmithKline's asthma drug Relvar approved in Europe
2013-11-18 15:25:07| Biotech - Topix.net
GlaxoSmithKline and Theravance's new inhaled lung drug Relvar has been approved in Europe to treat both asthma and chronic obstructive pulmonary disease , confirming an endorsement from regulators in September.
Tags: europe
approved
drug
asthma
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||